Fibromyalgia and bipolar disorder: extent of comorbidity and therapeutic implications

M C Di, F Carinci, G Lessiani, E Spinas, S K Kritas, G Ronconi, Al Caraffa, P Conti

Article ID: 4287
Vol 31, Issue 1, 2017
DOI: https://doi.org/10.54517/jbrha4287
Received: 6 June 2022; Accepted: 6 June 2022; Available online: 6 June 2022; Issue release: 6 June 2022

Abstract

Fibromyalgia (FM) is a syndrome that affects muscles and soft tissues. Presenting symptoms include chronic muscle pain, fatigue, sleep problems and psychological symptoms, including depression and anxiety. There exists strong evidence of a comorbidity between FM and Bipolar Disorder (BD). In this study, papers from 2006 to February 2016 that examined the comorbidity and etiological similarities of FM and BD were reviewed, as well as the therapeutic implications of these findings. The reviewed articles showed that an adequate psychiatric screening for BD is recommended in FM patients with depressive symptoms, in order to decrease administration of antidepressants for BD, due to the lack of proven efficacy, and to limit antidepressant-induced mania. Alternative therapies, such as agomelatine, memantine and psychotherapic treatment should be considered


Keywords

esophageal cancer;Barrett’s esophagus;Helicobacter Pylori;Barrett’s adenocarcinoma


References

Supporting Agencies



Copyright (c) 2017 M C Di Tommaso Morrison, F Carinci, G Lessiani, E Spinas, S K Kritas, G Ronconi, Al Caraffa, P Conti




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).